home / stock / tkphf / tkphf news


TKPHF News and Press, Takeda Pharmaceutical Co Ltd From 10/22/25

Stock Information

Company Name: Takeda Pharmaceutical Co Ltd
Stock Symbol: TKPHF
Market: OTC
Website: takeda.com

Menu

TKPHF TKPHF Quote TKPHF Short TKPHF News TKPHF Articles TKPHF Message Board
Get TKPHF Alerts

News, Short Squeeze, Breakout and More Instantly...

TKPHF - Innovent inks $11.4 billion cancer drug partnership with Japan's Takeda

2025-10-22 01:55:39 ET More on Innovent Biologics, Takeda Pharmaceutical Takeda: Excellent Pipeline Kaizen - 6 Drugs, $20 Billion Annually Takeda Pharmaceutical Company Limited (TAK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript Taked...

TKPHF - Why Johnson & Johnson Is Eyeing Protagonist Therapeutics: The Rationale

2025-10-13 10:09:05 ET Thesis It's been a busy week for Protagonist Therapeutics, Inc. (PGTX) in terms of news. They're a name that wouldn't have been on everyone's map before the interest shown by Johnson & Johnson ( JNJ ) ("J&J"); however, after last week, their stock ...

TKPHF - My Top 5 Biotech Stocks Big Pharma Could Buy Next

2025-10-06 13:29:00 ET On September 17 , the Fed began cutting interest rates again, which historically preceded Big Pharma's increased activity in the M&A space.... Read the full article on Seeking Alpha For further details see: My Top 5 Biotech Stocks Big Pharm...

TKPHF - Teva Pharmaceuticals: Pipeline Momentum Signals New Era For Investors

2025-09-25 11:42:45 ET Just over four months have passed since the publication of my last article , "Why Investors Should Watch Teva Despite Regional Risks," and during that time, the Teva Pharmaceutical Industries Limited (TEVA) share price has risen by 14%.... Read the full ...

TKPHF - Takeda: Excellent Pipeline Kaizen - 6 Drugs, $20 Billion Annually

2025-09-24 17:40:34 ET Introduction Takeda ( TAK ) is currently a unique biopharma case that may lead to opportunities for investors. While the company is facing significant valuation issues, particularly after the costly Shire acquisition, the company has performed deft kaizen to i...

TKPHF - Novavax: Endlessly Frustrating, Endlessly Fascinating - Warrants Rating Upgrade

2025-09-18 16:02:16 ET Investment Overview I have given Novavax, Inc. ( NVAX ) stock three straight Sell recommendations in my last three articles on the Gaithersburg, Maryland based vaccine maker, in October 2024 , February this year , and most recently, in June this ...

TKPHF - Takeda Pharmaceutical Company Limited (TAK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

2025-09-09 03:42:48 ET Takeda Pharmaceutical Company Limited (TAK) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 3:20 PM EDT... Read the full article on Seeking Alpha For further details see: Takeda Pharmaceutical Company Limited (TAK) Presents At...

TKPHF - Takeda Pharmaceutical Company Limited (TAK) Oveporexton (TAK-861) Investor Call On Phase 3 Narcolepsy Type 1 Data Presented At World Sleep 2025 (Transcript)

2025-09-08 16:51:43 ET Takeda Pharmaceutical Company Limited (TAK) Oveporexton (TAK-861) Investor Call on Phase 3 Narcolepsy Type 1 Data Presented at World Sleep 2025... Read the full article on Seeking Alpha For further details see: Takeda Pharmaceutical Company Limited (TA...

TKPHF - Pfizer: Still A Bargain Despite Kennedy's Anti-Vaccine Attacks

2025-09-05 09:07:06 ET Since my last article , "Pfizer's Turnaround Story Is Stronger Than You Think," Pfizer Inc. (PFE) has seen its stock price rise about 6.8% despite the growing negative sentiment toward it on social media, primarily fueled by critical and not always fai...

TKPHF - Novavax gets Japan nod for its COVID-19 vaccine, triggers Takeda payment

2025-09-04 09:03:11 ET More on Novavax Novavax, Inc. (NVAX) Q2 2025 Earnings Call Transcript Despite Revenue Jump, Novavax Appears Immune To Long-Term Growth Novavax: New Vaccine, Same Old Story - Still A Sell Pfizer, Moderna, Novavax respond to Trump’...

Previous 10 Next 10